4//SEC Filing
FUHS ULRICH MARTIN 4
Accession 0001626199-24-000072
CIK 0001626199other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 7:22 PM ET
Size
7.3 KB
Accession
0001626199-24-000072
Insider Transaction Report
Form 4
FUHS ULRICH MARTIN
Chief Accounting Officer
Transactions
- Exercise/Conversion
Stock Option (Right to buy)
2024-05-08−22,820→ 52,180 totalExercise: $12.07Exp: 2031-12-05→ Common Stock (22,820 underlying) - Exercise/Conversion
Common Stock
2024-05-08$12.07/sh+22,820$275,437→ 30,120 total
Footnotes (2)
- [F1]Includes 7,300 shares of common stock underlying a restricted stock unit grant made on March 14, 2024.
- [F2]1/4th of the shares subject to the option vested on November 30, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the reporting person continuing to be a service provider through each date.
Documents
Issuer
ALPINE IMMUNE SCIENCES, INC.
CIK 0001626199
Entity typeother
Related Parties
1- filerCIK 0002018119
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 7:22 PM ET
- Size
- 7.3 KB